Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000671692 | SCV000796692 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2B | 2017-12-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001381690 | SCV001580183 | pathogenic | Qualitative or quantitative defects of dysferlin | 2023-11-28 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Lys1609Argfs*4) in the DYSF gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DYSF are known to be pathogenic (PMID: 17698709, 20301480). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individual(s) with limb-girdle muscular dystrophy (LGMD) (PMID: 29970176). ClinVar contains an entry for this variant (Variation ID: 369690). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV004567872 | SCV005060257 | pathogenic | Miyoshi muscular dystrophy 1 | 2024-03-17 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV000408636 | SCV000484454 | pathogenic | Proximal muscle weakness | no assertion criteria provided | clinical testing |